160 related articles for article (PubMed ID: 29563787)
1. A facile doxorubicin-dichloroacetate conjugate nanomedicine with high drug loading for safe drug delivery.
Yang C; Wu T; Qin Y; Qi Y; Sun Y; Kong M; Jiang X; Qin X; Shen Y; Zhang Z
Int J Nanomedicine; 2018; 13():1281-1293. PubMed ID: 29563787
[TBL] [Abstract][Full Text] [Related]
2. Doxorubicin-loaded amphiphilic polypeptide-based nanoparticles as an efficient drug delivery system for cancer therapy.
Lv S; Li M; Tang Z; Song W; Sun H; Liu H; Chen X
Acta Biomater; 2013 Dec; 9(12):9330-42. PubMed ID: 23958784
[TBL] [Abstract][Full Text] [Related]
3. Improved delivery of doxorubicin using rationally designed PEGylated platinum nanoparticles for the treatment of melanoma.
Mukherjee S; Kotcherlakota R; Haque S; Bhattacharya D; Kumar JM; Chakravarty S; Patra CR
Mater Sci Eng C Mater Biol Appl; 2020 Mar; 108():110375. PubMed ID: 31924026
[TBL] [Abstract][Full Text] [Related]
4. Self-crosslinkable and intracellularly decrosslinkable biodegradable micellar nanoparticles: A robust, simple and multifunctional nanoplatform for high-efficiency targeted cancer chemotherapy.
Zou Y; Fang Y; Meng H; Meng F; Deng C; Zhang J; Zhong Z
J Control Release; 2016 Dec; 244(Pt B):326-335. PubMed ID: 27245309
[TBL] [Abstract][Full Text] [Related]
5. PEGylated Poly(α-lipoic acid) Loaded with Doxorubicin as a pH and Reduction Dual Responsive Nanomedicine for Breast Cancer Therapy.
Yang H; Shen W; Liu W; Chen L; Zhang P; Xiao C; Chen X
Biomacromolecules; 2018 Nov; 19(11):4492-4503. PubMed ID: 30346147
[TBL] [Abstract][Full Text] [Related]
6. Targeted hepatocellular carcinoma therapy: transferrin modified, self-assembled polymeric nanomedicine for co-delivery of cisplatin and doxorubicin.
Zhang X; Li J; Yan M
Drug Dev Ind Pharm; 2016 Oct; 42(10):1590-9. PubMed ID: 26942448
[TBL] [Abstract][Full Text] [Related]
7. Dual-responsive mPEG-PLGA-PGlu hybrid-core nanoparticles with a high drug loading to reverse the multidrug resistance of breast cancer: an in vitro and in vivo evaluation.
Xu H; Yang D; Cai C; Gou J; Zhang Y; Wang L; Zhong H; Tang X
Acta Biomater; 2015 Apr; 16():156-68. PubMed ID: 25662165
[TBL] [Abstract][Full Text] [Related]
8. Biocompatible cationic pullulan-g-desoxycholic acid-g-PEI micelles used to co-deliver drug and gene for cancer therapy.
Chen L; Ji F; Bao Y; Xia J; Guo L; Wang J; Li Y
Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):418-429. PubMed ID: 27770912
[TBL] [Abstract][Full Text] [Related]
9. Improving breast cancer therapy using doxorubicin loaded solid lipid nanoparticles: Synthesis of a novel arginine-glycine-aspartic tripeptide conjugated, pH sensitive lipid and evaluation of the nanomedicine in vitro and in vivo.
Zheng G; Zheng M; Yang B; Fu H; Li Y
Biomed Pharmacother; 2019 Aug; 116():109006. PubMed ID: 31152925
[TBL] [Abstract][Full Text] [Related]
10. Robust, active tumor-targeting and fast bioresponsive anticancer nanotherapeutics based on natural endogenous materials.
Sun B; Deng C; Meng F; Zhang J; Zhong Z
Acta Biomater; 2016 Nov; 45():223-233. PubMed ID: 27576338
[TBL] [Abstract][Full Text] [Related]
11. Efficient delivery of antitumor drug to the nuclei of tumor cells by amphiphilic biodegradable poly(L-aspartic acid-co-lactic acid)/DPPE co-polymer nanoparticles.
Han S; Liu Y; Nie X; Xu Q; Jiao F; Li W; Zhao Y; Wu Y; Chen C
Small; 2012 May; 8(10):1596-606. PubMed ID: 22411637
[TBL] [Abstract][Full Text] [Related]
12. Doxorubicin-loaded pH-sensitive micelles: A promising alternative to enhance antitumor activity and reduce toxicity.
Cavalcante CH; Fernandes RS; de Oliveira Silva J; Ramos Oda CM; Leite EA; Cassali GD; Charlie-Silva I; Ventura Fernandes BH; Miranda Ferreira LA; de Barros ALB
Biomed Pharmacother; 2021 Feb; 134():111076. PubMed ID: 33341054
[TBL] [Abstract][Full Text] [Related]
13. CD20 monoclonal antibody targeted nanoscale drug delivery system for doxorubicin chemotherapy: an in vitro study of cell lysis of CD20-positive Raji cells.
Jiang S; Wang X; Zhang Z; Sun L; Pu Y; Yao H; Li J; Liu Y; Zhang Y; Zhang W
Int J Nanomedicine; 2016; 11():5505-5518. PubMed ID: 27843311
[TBL] [Abstract][Full Text] [Related]
14. Doxorubicin and indocyanine green loaded superparamagnetic iron oxide nanoparticles with PEGylated phospholipid coating for magnetic resonance with fluorescence imaging and chemotherapy of glioma.
Shen C; Wang X; Zheng Z; Gao C; Chen X; Zhao S; Dai Z
Int J Nanomedicine; 2019; 14():101-117. PubMed ID: 30587988
[TBL] [Abstract][Full Text] [Related]
15. A tumor-targeting near-infrared laser-triggered drug delivery system based on GO@Ag nanoparticles for chemo-photothermal therapy and X-ray imaging.
Shi J; Wang L; Zhang J; Ma R; Gao J; Liu Y; Zhang C; Zhang Z
Biomaterials; 2014 Jul; 35(22):5847-61. PubMed ID: 24746963
[TBL] [Abstract][Full Text] [Related]
16. Reduction Responsive Self-Assembled Nanoparticles Based on Disulfide-Linked Drug-Drug Conjugate with High Drug Loading and Antitumor Efficacy.
Song Q; Wang X; Wang Y; Liang Y; Zhou Y; Song X; He B; Zhang H; Dai W; Wang X; Zhang Q
Mol Pharm; 2016 Jan; 13(1):190-201. PubMed ID: 26629710
[TBL] [Abstract][Full Text] [Related]
17. Zwitterionic nanoparticles constructed from bioreducible RAFT-ROP double head agent for shell shedding triggered intracellular drug delivery.
Huang P; Liu J; Wang W; Zhang Y; Zhao F; Kong D; Liu J; Dong A
Acta Biomater; 2016 Aug; 40():263-272. PubMed ID: 26607767
[TBL] [Abstract][Full Text] [Related]
18. Aptamer-drug conjugate: targeted delivery of doxorubicin in a HER3 aptamer-functionalized liposomal delivery system reduces cardiotoxicity.
Dou XQ; Wang H; Zhang J; Wang F; Xu GL; Xu CC; Xu HH; Xiang SS; Fu J; Song HF
Int J Nanomedicine; 2018; 13():763-776. PubMed ID: 29440899
[TBL] [Abstract][Full Text] [Related]
19. Hyaluronic acid-capped compact silica-supported mesoporous titania nanoparticles for ligand-directed delivery of doxorubicin.
Gupta B; Poudel BK; Ruttala HB; Regmi S; Pathak S; Gautam M; Jin SG; Jeong JH; Choi HG; Ku SK; Yong CS; Kim JO
Acta Biomater; 2018 Oct; 80():364-377. PubMed ID: 30201431
[TBL] [Abstract][Full Text] [Related]
20. Codelivery of doxorubicin and elacridar to target both liver cancer cells and stem cells by polylactide-co-glycolide/d-alpha-tocopherol polyethylene glycol 1000 succinate nanoparticles.
Chen D; Pan X; Xie F; Lu Y; Zou H; Yin C; Zhang Y; Gao J
Int J Nanomedicine; 2018; 13():6855-6870. PubMed ID: 30498347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
